Global Neurological Biomarkers Industry is poised to reach a valuation of US$ 12.5 Billion by 2033, maintaining a steady CAGR of 4.6% | FMI

The global neurological biomarkers industry is set to witness exponential growth, projected at a robust Compound Annual Growth Rate (CAGR) of 4.6% over the forecast period. According to market analyses, the sector, valued at US$ 8 billion in 2023, is anticipated to soar to an estimated US$ 12.5 billion by 2033, signifying a significant upward …

Global Neurological Biomarkers Industry might hit a monumental US$ 12.5 Billion by 2033 | FMI

The global neurological biomarkers industry demand is predicted to grow quickly over the course of the forecast period, at a CAGR of 4.6%. In 2023, it is anticipated that the market for neurological biomarkers would be worth US$ 8 billion. The market for neurological biomarkers is predicted to reach a peak of US$ 12.5 billion …